Treatment of MCD-fed mice with the GPX4 activator sodium selenite increased hepatic GPX4 expression and decreased the severity of NASH, indicating that GPX4 levels were impaired in NASH patients and therefore caused lipid peroxidation-induced ferroptosis (48). The gene discussed is GPX4; the disease is metabolic dysfunction-associated steatohepatitis.